Allink Biotherapeutics Raises $42M Series A Financing to Accelerate Global Development of Bispecific Antibody and ADC Pipeline ...Middle East

The series A investment round secures resources for advancing global Phase I/II clinical programs and orchestrating the company's global footprint expansion. SHANGHAI, Nov. 28, 2024 /PRNewswire/ -- Allink Biotherapeutics, a clinical-stage biotechnology company pioneering next-generation...

Read More Details
Finally We wish PressBee provided you with enough information of ( Allink Biotherapeutics Raises $42M Series A Financing to Accelerate Global Development of Bispecific Antibody and ADC Pipeline )

Also on site :

• Diddy Trial Recap: Kid Cudi Testifies About Home Break-In and Porsche Molotov Cocktail Explosion
• Matthew Goode Explains Absence From ‘Downton Abbey 3’: “Maybe It’s A Good Thing”
• Columbia student activist seized by ICE agents holds month-old son for first time after 10 weeks of detention